This post has been archived and contains information that may be out of date.
The California Department of Public Health (CDPH) has issued All Facilities Letter (AFL) 23-29, recommending that all residents of skilled-nursing facilities (SNFs) with symptomatic COVID-19 be evaluated by a prescribing clinician to be considered for COVID-19 therapeutics, any oral COVID-19 therapeutics drug-drug interaction risk, and/or renal and hepatic impairment in advance of a COVID-19 diagnosis.
Additionally, CDPH notes that SNFs should record such information in health records in order to facilitate resident access to appropriate therapeutics when a COVID-19 diagnosis is made. This AFL also provides information regarding available guidance and resources for evaluating, prescribing, and obtaining COVID-19 therapeutics for SNF residents and recommends SNFs provide information on appropriate therapeutics to their health care personnel who have symptomatic COVID-19. This AFL revision includes the latest authorized COVID-19 treatments with the recommended timing for effectiveness.
